Guide Prescrire is a clinical decision support tool for healthcare professionals, providing evidence-based treatment guidance for first-line care on iOS and Android.
The App DNA
What makes this app unique?
Clinicians need rapid, reliable access to safety and efficacy data during patient consultations to minimize diagnostic friction and improve treatment outcomes.
For Healthcare professionals and clinicians seeking evidence-based, first-line treatment guidance.
What does it look like?
Key features
Provides treatment guidance for first-line care situations based on efficacy and safety data.
Allows access to a limited set of practical clinical situations without an active subscription.
Structures medical data for rapid retrieval during patient consultations and advisory sessions.
How much does it cost?
The app functions as a value-add component of the broader Prescrire subscription, using a discovery mode to drive conversion.
Velocity
Maintenance developmentUX improvementsperformanceShow more...
The app has been in a maintenance phase for over 8 months, with the latest release occurring 254 days ago. Development activity is limited to minor bug fixes and visual identity updates, with no evidence of new features or live operations. The current cadence of two releases in the observed window confirms a long-term stagnation in development momentum.
Who built it?
Association Mieux Prescrire
3 apps tracked · Medical
Application Prescrire
Guide PrescrireUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Guide Prescrire
How's the Medical market?
Guide Prescrire maintains a specialized position in the medical category, focusing on evidence-based guidance rather than broad-market health tracking. The 8-month update gap signals a maintenance-only posture that prioritizes content stability over feature expansion.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Guide Prescrire
Where is it heading?
The medical decision support market is shifting toward real-time, integrated data feeds that require frequent updates. Guide Prescrire's current maintenance-only posture leaves it exposed to more dynamic competitors, necessitating a shift toward automated content delivery to maintain clinical relevance.
- The 8-month release cadence indicates a maintenance-only posture, which limits the app's ability to integrate real-time medical guideline updates.
The SWOT
- Structured clinical data enables rapid retrieval during consultations
- Localized clinical guidance could expand the user base
Next best moves
Audit clinical content update pipeline because the 8-month release cadence risks data obsolescence → improve clinical trust
The counter-intuitive read
The app's slow update cadence is a feature, not a bug…
Read the full takeSince the last report: The assessment of the app's maintenance-only update cycle has intensified, moving from a neutral observation to a high-priority risk factor for clinical trust and data accuracy.
Bottom line
Guide Prescrire relies on the strength of its evidence-based content, but the current maintenance-only release cycle threatens its utility as a clinical tool. Automating the content-sync pipeline would address the obsolescence risk, ensuring the app remains a reliable resource for clinicians.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
Report last updated